With the constant development of imaging-guided percutaneous tumor ablation technology, its safety and efficacy have been recognized by clinical physicians as well as by patients. It has played a more and more important role in the modern minimally- invasive treatment for liver tumors. However, great differences in technique level of operation, the experience of physician, the function of the equipment, and patient’s condition exist between different medical units. The therapeutic efficacy, recurrence rate and complication rate are also quite different from one hospital to another. In order to resolve the problems mentioned above and to further improve the clinical efficacy and safety of ablation therapy , the establishment of an agreement on ablation indication, treatment strategy of standardization and individualization, and standardized operation procedure and technique in China is mandatory at present. Besides, to formulate the license policy, to improve knowledge compensation from multiple clinical disciplines and to pay great attention to treatment standardization, etc. all are important means in order to improve the overall efficacy of liver tumor ablation in our country.